World's Best Scientists 2026 revealed!
Jérôme Galon

Jérôme Galon

Award Badge
Immunology
France
2023
Award Badge
Medicine
France
2023

D-Index & Metrics

Immunology

D-Index
101
Citations
75377
World Ranking
687
National Ranking
22

Medicine

D-Index
102
Citations
75540
World Ranking
7477
National Ranking
232

Jérôme Galon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jérôme Galon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 345 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jérôme Galon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jérôme Galon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 101 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Immunology in France Leader Award
  • 2023 - Research.com Medicine in France Leader Award
  • 2022 - Research.com Immunology in France Leader Award

Overview

Jérôme Galon is affiliated with Inserm in France and specializes in medicine with a primary focus on oncology. Their research spans several subfields including oncology, immunology, pathology and forensic medicine, cancer research, and surgery. The scientist's work primarily addresses topics related to cancer immunotherapy and biomarkers, colorectal cancer treatments and studies, immunotherapy and immune responses, genetic factors in colorectal cancer, cancer genomics and diagnostics, CAR-T cell therapy research, and colorectal and anal carcinomas.

Their publication record includes significant papers such as:

  • The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy (2020, Nature Reviews. Cancer)
  • Tumor Immunology and Tumor Evolution: Intertwined Histories (2020, Immunity)
  • Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer (2022, Cell)
  • Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial (2022, The Lancet Oncology)
  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer (2020, Journal of Clinical Oncology)

Jérôme Galon has collaborated frequently with several coauthors, notably:

  • Franck Pagès
  • Bernhard Mlecnik
  • Marc Van den Eynde
  • Florence Marliot
  • Aurélie Catteau

The scientist's publications have appeared consistently in leading journals with a high number of articles published in these venues:

  • Journal of Clinical Oncology (17 publications)
  • OncoImmunology (17 publications)
  • Annals of Oncology (14 publications)
  • Cancers (10 publications)
  • Cancer Research (8 publications)

The research profile of Jérôme Galon is characterized by a consistent attention to cancer immunology and colorectal cancer. Their work encompasses both the biological and clinical aspects of cancer, including the evolving role of immune responses and the development of diagnostic and therapeutic biomarkers.

Best Publications

  • Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

    Jérôme Galon;Anne Costes;Fatima Sanchez-Cabo;Amos Kirilovsky

  • ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

    Gabriela-Luana Bindea;Bernhard Mlecnik;Hubert Hackl;Pornpimol Charoentong

  • The immune contexture in human tumours: impact on clinical outcome

    Wolf Herman Fridman;Franck Pagès;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Jérôme Galon

  • Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

    Gabriela Bindea;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Marie Tosolini;Marie Tosolini;Marie Tosolini;Amos Kirilovsky;Amos Kirilovsky;Amos Kirilovsky

  • Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

    Jérôme Galon;Daniela Bruni

  • Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer

    Franck Pagès;Anne Berger;Matthieu Camus;Fatima Sanchez-Cabo

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • GERMLINE MUTATIONS IN THE EXTRACELLULAR DOMAINS OF THE 55 KDA TNF RECEPTOR, TNFR1, DEFINE A FAMILY OF DOMINANTLY INHERITED AUTOINFLAMMATORY SYNDROMES

    Michael F McDermott;Ivona Aksentijevich;Jérôme Galon;Elizabeth M McDermott

  • The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

    Daniela Bruni;Helen K Angell;Jérôme Galon

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer

    David D. Bowtell;David D. Bowtell;Steffen Böhm;Ahmed A. Ahmed;Paul Joseph Aspuria

  • Immune infiltration in human tumors: a prognostic factor that should not be ignored.

    Pagès F;Galon J;Galon J;Galon J;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Tartour E

  • Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

    Marie Tosolini;Amos Kirilovsky;Bernhard Mlecnik;Tessa Fredriksen

  • CluePedia Cytoscape plugin

    Gabriela Bindea;Jérôme Galon;Bernhard Mlecnik

  • Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction

    Bernhard Mlecnik;Marie Tosolini;Amos Kirilovsky;Anne Berger

  • In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

    Franck Pages;Amos Kirilovsky;Bernhard Mlecnik;Martin Asslaber

  • Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability

    Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Pauline Maby

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures

    Jérôme Galon;Helen K. Angell;Helen K. Angell;Helen K. Angell;Davide Bedognetti;Francesco M. Marincola;Francesco M. Marincola

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

Frequent Co-Authors

Guido Kroemer
Guido Kroemer Université Paris Cité
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Catherine Sautès-Fridman
Catherine Sautès-Fridman Université Paris Cité
Wolf H. Fridman
Wolf H. Fridman Université Paris Cité
Erika Vacchelli
Erika Vacchelli Université Paris Cité
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health
Isabelle Cremer
Isabelle Cremer Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding into nursing-related fields offers diverse opportunities. Many students consider programs like accelerated nursing programs to fast-track their entry into the healthcare workforce, gaining essential patient care experience that complements immunological knowledge.

Non-nurses seeking to enter the field can explore the best online RN programs for non nurses. These programs provide a solid foundation in nursing practice, opening doors to specialized roles involving immunology and patient care.

Advanced studies, such as an accelerated nurse practitioner program, further enable individuals to deliver higher-level clinical care and contribute to immunological research and treatment advances.

For current Family Nurse Practitioners (FNPs) aiming to broaden their expertise in critical care related to immunological disorders, understanding the pathway to the fnp to acute care certification is essential. This transition expands career options and deepens clinical impact in immunology-focused settings.

Best Scientists Citing Jérôme Galon

Trending Scientists

Recently Published Articles